FindTrial
Sign In

Assessing the effect of endometrioma on ovarian reserve

Comparison of serum anti müllerian hormone (AMH)levels as a marker of ovarian reserve in reproductive age women with and without endometrioma - A Cross-sectional analytical study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/066913
Enrollment
192
Registered
2024-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N801- Endometriosis of ovary

Interventions

Control Intervention1: Nil: Nil

Sponsors

Jawaharlal Institute of Postgraduate Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women between 18-39 years of age Women with regular menstrual cycles

Exclusion criteria

Exclusion criteria: Known case of endometrima underwent cystectomy or surgeries Women diagnosed with pcos Women underwent chemotherapy or radiotherapy Women on hormonal therapy irrespective of indications

Design outcomes

Primary

MeasureTime frame
Compare serum AMH levels between patients with and without endometriomaTimepoint: Baseline—

Secondary

MeasureTime frame
Correlation between size of endometrioma and AMH levels Correlation between USG pattern of endometrioma and AMH levelsTimepoint: Baseline—

Countries

India

Contacts

Public ContactDr Sujatha V

Jawaharlal Institute of Postgraduate Medical Education and Research Puducherry

drsujatharaman@gmail.com7598500890

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026